LY2886721: Potent Oral BACE1 Inhibitor for Alzheimer's Di...
2026-01-20
LY2886721 is a small-molecule BACE1 inhibitor used in Alzheimer's disease research to reduce amyloid beta levels. Its nanomolar potency, oral bioavailability, and proven synaptic safety profile make it a benchmark tool for studying amyloid precursor protein processing and Aβ peptide formation pathways.